CDK2 and cancer: Nevertheless, while Cdk2 knockdown (KD) in p53-proficient U2OS and HCT-116 or p53-deficient HeLa cancer cell lines markedly diminished Chk1 phosphorylation by HU, the effect on S-phase arrest was rather modest.